Today's Hours: Closed
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    edited by Krishnan Padmakumari Sivaraman Nair, Marlis Gonzalez-Fernandez, Jalesh N. Panicker.
    Summary: Cognitive impairment, dysphagia, communication issues, pain, spasticity, bladder dysfunction, sexual dysfunction and bowel incontinence are but a few problems frequently reported by individuals living with long-term neurological conditions. The management of long-term neurological conditions requires co-ordinated inputs from multiple disciplines, and this practical handbook facilitates this by combining physical, cognitive and psychological strategies to patient management. Featuring contributions from leading experts in neurology, health services and clinical rehabilitation, this book is a comprehensive overview of common neurological impairments and solutions. It adopts an evidence-based approach to both pharmacological and non-pharmacological options for alleviating neurological symptoms. An easy-to-refer to guide, bridging multiple disciplines, aided by current research, to provide effective, and practical management for all aspects and issues arising in the rehabilitation phases of the neurological patient. This unique pocketbook is intended for practitioners at all levels, and is ideally suited as a quick guide during ward rounds, out-patient clinics and therapy sessions.

    Contents:
    An introduction to neurological rehabilitation / Diane Playford and Krishnan Padmakumari Sivaraman Nair
    Management of disorders of cognition in neurorehabilitation / Pegah Touradji and Anna V. Agranovich
    Management of mood and behaviour in neurorehabilitation / Lewys Morgan and Abhijeeth Shetty
    Management of disorders of consciousness in neurorehabilitation / Andreas Bender
    Management of communication disorders in neurorehabilitation / Rajani Sebastian and Donna C. Tippett
    Management of disorders of eating, drinking, and swallowing in Neurorehabilitation / Rachel Mulheren, Alba Azola and Marlis Gonzalez-Fernandez
    Management of salivary disorders in neurorehabilitation / Nicole Rogus-Pulia, Joanne Yee and Korey Kennelty
    Management of upper limb impairment in neurorehabilitation / Preeti Raghavan and Manuel Wilfred
    Management of vestibular disorders in neurorehabilitation / Adolfo M. Bronstein and Marousa Pavlou
    Management of walking disorders in neurorehabilitation / Jonathan F. Marsden
    Management of spasticity in neurorehabilitation / Valerie L. Stevenson
    Neurorehabilitation in parkinson's disease and parkinsonism / Amit Batla and Fiona Lindop
    Neuropathic pain / Alina Zakin and David M. Simpson
    Management of phantom limb in neurorehabilitation / Rohit Bhide and Apurba Barman
    Management of neuro-ophthalmologic disorders in neurorehabilitation / Simon J. Hickman and Martin J. Rhodes
    Management of pressure ulcers in neurological rehabilitation / Ramaswamy Hariharan and Anand Viswanathan
    Management of disorders of blood pressure control in neurorehabilitation / Ellen Merete Hagen
    Management of neurogenic lower urinary tract dysfunction / Mahreen Pakzad and Pierre Denys
    Management of neurogenic bowel dysfunction / Anton Emmanuel
    Management of neurogenic sexual dysfunction / Gila Bronner and Tanya Gurevich.
    Digital Access Cambridge 2018
  • Journal
    Print v. 1- ; 1958-
  • Article
    Tojo S, Narita M, Koyama A, Sano M, Suzuki H, Tsuchiya T, Tsuchida H, Yamamoto S, Shishido H.
    Contrib Nephrol. 1978;9:111-27.
    Dipyridamole was used in 30 cases of nephrotic syndrome, mostly of intractable type. The results indicate that the drug therapy proved to be effective in decreasing urinary protein and controlling nephrotic condition in 40% of the cases after an initial period of treatment. Long-term results of the drug on urinary protein and on nephrotic condition were rated as good in 36.7 and 53.3%, respectively, of the cases treated. The exact mechanism of action of dipyridamole in the nephrotic syndrome is still obscure in many respects. However, the fact that the drug shares its anti-platelet action with the non-steroid anti-inflammatory drugs, e.g. aspirin and indomethacin, and the rapidity with which it produces its urinary protein-decreasing effect, strongly suggests that it inhibits the release of vasoactive amines and other chemical mediators from blood platelets. As far as the present study is concerned, adverse side effects of dipyridamole were few or minimal, even when the drug used in large doses over a prolonged period of time. From these results it is considered that dipyridamole provides a new remedy which is worthy of trying in nephrotic syndrome as a means of reducing the requirement of steroids and immunosuppressive drugs.
    Digital Access Access Options